EC Number   |
Expression |
Reference |
|---|
   2.1.1.325 | down |
enzyme transcription is suppressed during metamorphosis |
738378 |
| 2.1.1.325 | down |
in females, the enzyme expression levels are significantly downregulated in eyestalk during ovarian development |
738960 |
| 2.1.1.325 | down |
mRNA levels are reduced in starved females and in females in which nutritional signaling is reduced by knocking down insulin receptor and target of rapamycin |
756917 |
| 2.1.1.325 | down |
the enzyme's mRNA level gradually declines during larval development, and the lowest amount of expression is observed in the pupal stage, while it increases to a higher level during adult stages |
738112 |
| 2.1.1.325 | down |
treatment with mandibular organ-inhibiting hormone leads to a significant decline in enzyme activity and mRNA levels after 5h |
738075 |
| 2.1.1.325 | more |
transcript levels of the enzyme are not up-regulated by 20-hydroxyecdysone |
738381 |
| 2.1.1.325 | up |
enzyme activity is increases about 18fold 14 days after eyestalk ablation |
738075 |
| 2.1.1.325 | up |
enzyme expression significantly increases in the late-vitellogenic stage and mature stage of ovarian development |
737454 |
| 2.1.1.325 | up |
in females, the enzyme expression levels are significantly up-regulated in thoracic ganglion during ovarian development, while in males expression levels increase in both thoracic ganglion and eyestalk during testicular development stages |
738960 |
| 2.1.1.325 | up |
in ovarian development, the mRNA level of the enzyme remains low in stage I and II, then increases considerably to a maximum in stage III, and declines slightly in stage IV |
737795 |
